Cosmo Pharmaceuticals sees highest patent filings and grants during August in Q3 2023
Cosmo Pharmaceuticals saw the highest growth of 399% in patent filings and 499% in grants in August in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 99% and grants by 99%. GlobalData's DataBook provides a comprehensive analysis of Cosmo Pharmaceuticals's patent filings and grants. Buy the databook here.Cosmo Pharmaceuticals has been focused on protecting inventions in United States(US) with 3 publications in Q3 2023The United States(US) Patent Office dominates the patent filings and grants with nearly 40% filings and 14% grants. The United States(US), Denmark(DK), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Cosmo Pharmaceuticals is filings its patents. Among the top granted patent authorities, Cosmo Pharmaceuticals has 14% of its grants in United States(US), 14% in Spain(ES), and 14% in Finland(FI).Johnson & Johnson could be the strongest competitor for Cosmo PharmaceuticalsJohnson & Johnson and Sanofi secured the top positions according to recent patent publication data.Patents related to healthtech and artificial intelligence lead Cosmo Pharmaceuticals's portfolioCosmo Pharmaceuticals has the highest number of patents in healthtech followed by, artificial intelligence and data science. For healthtech, nearly 22% of patents were filed and 22% of patents were granted in Q3 2023.Active and passive safety related patents lead Cosmo Pharmaceuticals portfolio followed by mos micro (mpu, mcu & dsp), and digital signal processors(dsp)Cosmo Pharmaceuticals has highest number of patents in active and passive safety followed by mos micro (mpu, mcu & dsp), digital signal processors(dsp), image management and healthcare it. For active and passive safety, nearly 15% of patents were filed and 15% of patents were granted in Q3 2023.For comprehensive analysis of Cosmo Pharmaceuticals's filings and grants, buy the databook here.
Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.
What's Your Reaction?
